ecrin-mdr-crcClinical2013liver only metastasis from KRAS Exon 2 wild type (under protocol 1.0-1.2 edition) and RAS wild type (under protocol 2.0 edition) colorectal cancerNeoplasm MetastasisNeoplasms, Second PrimaryColorectal CancerLiver MetastasisColorectal NeoplasmsNeoplasm MetastasisNeoplasms, Second PrimaryLiver Only Metastasis From Kras Exon 2 Wild Type (under Protocol 1.0-1.2 Edition) And Ras Wild Type (under Protocol 2.0 Edition) Colorectal CancerColorectal CancerLiver MetastasisColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2143313Japan5OxaliplatinLiver only metastasis from KRAS Exon 2 wild typeCetuximabLiver only metastasis from RAS wild typeFluorouracilBevacizumabECRIN MDRCompletedfalseExploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesThe correlation between the values of angiogenesis-related growth factors in plasma and efficacy, and biomarkers relevant as prognostic factors or predictive factors for sensitivity or resistance to treatment will be examined exploratively.2013-05-152143313UMIN000010429NCT01834014JPRN-UMIN000010429